HEART-FID trial finds no significant benefit from ferric carboxymaltose in heart failure patient outcomes

by

A trial led by the Duke Clinical Research Institute, Durham, has investigated the long-term safety and efficacy of supplementing heart failure patients with iron.

Leave A Comment

Your email address will not be published. Required fields are marked *